Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart ring replace the blood pressure cuff for dialysis patients?

NCT ID NCT07753876

Knowledge-focused Sponsor: Gangnam Severance Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 25, 2026 · Updated 3 times

Summary

This study tests whether a ring-shaped, cuffless device called CART BP Pro can accurately measure blood pressure in people receiving maintenance hemodialysis. Participants will wear the device on their finger for about 48 hours, and its readings will be compared with standard blood pressure measurements. The study also looks at whether the device's readings are consistent over time and whether they relate to heart health indicators. The goal is to see if this wearable could offer a more convenient and continuous way to monitor blood pressure in this population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CART BP Pro, a cuffless ring-type blood pressure monitoring device worn on the finger
What this could lead to
If validated, this device could offer a more comfortable and continuous way to monitor blood pressure in dialysis patients, potentially improving cardiovascular risk prediction.
What could go wrong
The device may not match the accuracy of traditional methods, and the study is observational, so it cannot prove that using the device improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 240 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients receiving maintenance hemodialysis for at least 3 months at Gangnam Severance Hospital, Yongin Severance Hospital, and Catholic Kwandong University International St. Mary's Hospital in South Korea will be screened for eligibility. Patients who meet the inclusion and exclusion criteria and provide written informed consent will be prospectively enrolled in the study.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older * Receiving maintenance hemodialysis three times per week * Receiving maintenance hemodialysis for at least 3 months * Able and willing to provide written informed consent Exclusion Criteria: * Presence of a cardiac pacemaker or clinically significant arrhythmia (e.g., atrial fibrillation). Patients with paroxysmal atrial fibrillation are eligible for enrollment. * Unable to wear the CART BP Pro device (e.g., finger deformity) * Expected survival of less than 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End-stage renal disease ESRD on HD

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gangnam Severance Hospital

    Seoul, 06273, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.